Five years after setting out to manufacture the delicate tissue that enables the human eye to see clearly, Cellular Bioengineering Inc. has completed 10 successful cornea implants abroad.
The Honolulu biotechnology firm’s patented material for artificial corneas is being manufactured locally and last December was used for eye surgeries in Europe.
Cellular Bioengineering founder and CEO Hank Wuh said the pilot tests help validate the material’s effectiveness, with all patients — who ranged in age from 16 to 75 — regaining sight....read more.
No comments:
Post a Comment